Let's Get Real About PrEP
Infectious DiseasesLet's Get Real About PrEP
1.5 AMA PRA Category 1 Credit(s) ™
August 24, 2017
The accreditation for this activity has expired.
Primary Audience:
Front-line healthcare providers, primary care physicians, OB/GYNs
Relevant Terms:
HIV, HIV prevention, PrEP
Richard A. Elion, MD
Richard A. Elion, MD
Associate Clinical Professor of Medicine
George Washington University
Director, Department of Clinical Investigations
Whitman-Walker Health
Washington, DC
Bio
Richard Elion is a Clinical Professor of Medicine at George Washington University School of Medicine and an Adjunct Professor in the Milliken School of Public Health at GW as well. Dr. Elion is co-director of the HIV/HCV clinical and research program at Providence Hospital. He also serves as Vice President of Strategy for Trio Health. Dr. Elion graduated from the Temple University School of Medicine and did his residency at Duke University Medical Center. He has also completed the course work for a Masters in Counseling from University of Santa Monica. Dr. Elion has also been an active investigator in HIV prevention and PrEP and was the principal investigator in the PrEP demo project recently published in JAMA.
Dr. Elion has had an active clinical practice for over thirty years and had been the Prinicipal Investigator of numerous clinical trials including the newly formed Aids Clinical Trial Group site in Washington DC as well as the PI for the Multicenter Aids Cohort Study in conjunction with Johns Hopkins. He was a founding member of the American Academy of HIV Medicine and a past board member of the HIVMA, a division of the IDSA. He is working on various HIV prevention projects with the Department of Health and converting a city-wide STD program into a center for prevention studies.
Dr. Elion has also been active in HCV treatment for over twenty years, both in clinical care and research. He has published on the pivotal trials of some of the new DAA agents for HCV, and worked closely to develop clinical and research protocols for HCV while at his past job, Whitman-Walker Health. He currently focuses on both mono- and dual- infected patients in his clinical work.
Donna E. Sweet, MD, AAHIVS, MACP
Donna E. Sweet, MD, AAHIVS, MACP
Professor of Medicine
University of Kansas School of Medicine-Wichita
Director, KU Wichita Internal Medicine Midtown and Ryan White Programs
Director and Principal Investigator
Kansas AIDS Education and Training Center
Wichita, KS
Bio
Dr. Sweet is Professor of Internal Medicine at the University of Kansas School of Medicine-Wichita (UKSM-W) and has over 30 years in HIV care. She is the medical director of the UKSM-W Ryan White HIV/AIDS Care Program (Parts B, C, D and F along with a HOPWA grant program).
Dr. Sweet is certified as an HIV specialist by the American Academy of HIV Medicine, of which she is the past board Chair and a founding member. Dr. Sweet has travelled extensively nationally and internationally educating physicians about HIV care and treatment.
| 1. | Identify environmental and other patient factors that increase an individual's risk of HIV acquisition | 2. | Explain what clinical trials have shown about PrEP's effectiveness and safety in HIV prevention |
| 3. | Identify requirements to prescribe and monitor PrEP based on CDC guidelines |
| 1. | Identify environmental and other patient factors that increase an individual's risk of HIV acquisition |
| 2. | Explain what clinical trials have shown about PrEP's effectiveness and safety in HIV prevention |
| 3. | Identify requirements to prescribe and monitor PrEP based on CDC guidelines |
and 
Knowledge and Competence
- a 1-hour online self-study completed at the learners' convenience, and
- a 30-minute live Office Hours Webinar with faculty on September 28, 2017 at 1 PM Eastern Time, which will be archived for learners who cannot attend the live session.
- Identify environmental and other patient factors that increase an individual's risk of HIV acquisition
- Explain what clinical trials have shown about PrEP's effectiveness and safety in HIV prevention
- Identify requirements to prescribe and monitor PrEP based on CDC guidelines
Credit Designation
| Supported Browsers: Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6.0+ for Mac OSX 10.7 and above | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above. |
Albert Einstein College of Medicine, Center for Continuing Medical Education (Einstein) protects the privacy of personal and other information regarding participants and educational collaborators. Einstein will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the ACCME.
Einstein maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.
Additional information regarding Albert Einstein College of Medicine's Privacy Policy can be viewed at https://www.mecme.org/PrivacyStatement.aspx.
Copyright © 2017 Albert Einstein College of Medicine and NovaMed Education, Inc. All rights reserved. No part of this material may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations.
